Abstract
Few communications were devoted this year to the cancers of the male external genital organs. In stade I testis seminomas, data comparing 1 course of chemotherapy by carboplatin (AUC: 7) to retroperitoneal radiotherapy in adjuvant treatment were updated. Localizations of recurrences were different, depending on adjuvant treatment. In stage I non seminomatous testis cancer, active surveillance could be possible if there were not any vascular embols. Chemotherapy by 1 course of BEP was superior to retroperitoneal lymph node dissection in stage I. In Leydig cell tumors, conservative surgery was possible. In penile cancer management, dynamic sentinel node biopsy could be interesting. Carbon-dioxide laser microsurgery only for initially invasive squamous cell carcinoma of the penis could be proposed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
